General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Annual results

Annual Results 2012 - Jan 23, 2013

Media release

  • Annual Report 2012 cover

    Form 20-F 2012

    Documents Novartis strategy in line with requirements of the US Securities and Exchange Commission (SEC)



Annual Report 2012

The Novartis Annual Report 2012 reviews the company’s strategy and annual performance. Novartis commissioned documentary filmmaker Martin Bell to produce a series of short films to complement photography by Mary Ellen Mark that illustrates the Annual Report.

Download the Annual Report 2012:

 

Stock chart